Asthma
Research Finding Could Revolutionize Asthma Treatment
Published in Medical Letter on the CDC and FDA, March 15th, 2009
Dean Smith, Executive Director of the American Asthma Foundation (AAF), said, "Drugs known as beta blockers have long been used to treat high blood pressure. However, they have historically been forbidden for patients with asthma, because they may make the symptoms worse. Now, however, results from a research study funded by the American Asthma Foundation suggest that, over the long run, asthma may well improve with low daily doses of beta blockers."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Scripps Research Institute
Scripps research scientists develop general-purpose method for detecting trace chemicals - Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals Reports Fourth Quarter and 2008 Financial Results - Aneurysm
Endovascular Repair Results in Decrease of Total Aneurysm Deaths - Breast Implants
Investigators at Allergan, Inc. have published new data on breast implants - Gout
New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat) - Life Sciences
Data from S. Tsai and colleagues advance knowledge in life sciences - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
